Poractant Alfa
Drug
Chiesi USA, Inc.
Total Payments
$266,292
Transactions
92
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $266,292 | 92 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $266,292 | 92 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CCD-5633AA1-02 | Chiesi USA, Inc. | $266,292 | 0 |
Top Doctors Receiving Payments for Poractant Alfa
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cincinnati, OH | $266,292 | 92 |
Ad
Manufacturing Companies
- Chiesi USA, Inc. $266,292
Product Information
- Type Drug
- Total Payments $266,292
- Total Doctors 0
- Transactions 92
About Poractant Alfa
Poractant Alfa is a drug associated with $266,292 in payments to 0 healthcare providers, recorded across 92 transactions in the CMS Open Payments database. The primary manufacturer is Chiesi USA, Inc..
Payment data is available from 2017 to 2017. In 2017, $266,292 was paid across 92 transactions to 0 doctors.
The most common payment nature for Poractant Alfa is "Unspecified" ($266,292, 100.0% of total).
Poractant Alfa is associated with 1 research study, including "CCD-5633AA1-02" ($266,292).